APA

Taçyıldız N., Tanyıldız H. G., Ünal E., Dinçaslan H., Asarcıklı F., Aksoy B. A., Vatansever G. & Yavuz G. (20200721). A targeted salvage therapy with Brentuximab vedotin in heavily treated refractory or relapsed pediatric Hodgkin lymphoma patients before and after stem cell transplantation. : The Turkish journal of pediatrics.

Chicago

Taçyıldız Nurdan, Tanyıldız Hikmet Gülşah, Ünal Emel, Dinçaslan Handan, Asarcıklı Fikret, Aksoy Başak Adaklı, Vatansever Göksel and Yavuz Gülsan. 20200721. A targeted salvage therapy with Brentuximab vedotin in heavily treated refractory or relapsed pediatric Hodgkin lymphoma patients before and after stem cell transplantation. : The Turkish journal of pediatrics.

Harvard

Taçyıldız N., Tanyıldız H. G., Ünal E., Dinçaslan H., Asarcıklı F., Aksoy B. A., Vatansever G. and Yavuz G. (20200721). A targeted salvage therapy with Brentuximab vedotin in heavily treated refractory or relapsed pediatric Hodgkin lymphoma patients before and after stem cell transplantation. : The Turkish journal of pediatrics.

MLA

Taçyıldız Nurdan, Tanyıldız Hikmet Gülşah, Ünal Emel, Dinçaslan Handan, Asarcıklı Fikret, Aksoy Başak Adaklı, Vatansever Göksel and Yavuz Gülsan. A targeted salvage therapy with Brentuximab vedotin in heavily treated refractory or relapsed pediatric Hodgkin lymphoma patients before and after stem cell transplantation. : The Turkish journal of pediatrics. 20200721.